Patents/Assignees

Nxera Pharma UK Limited

15 patents in portfolio

US12552799utility2026
Triazolone Compounds
0 cites
US12528815utility2026
5-amino-8-(4-pyridyl)-[1,2,4]triazolo[4,3-c]pyrimidin-3-one Compounds for Use Against Cancer
0 cites
US12492174utility2025
Morpholine-3-carboxamide Derivatives as Prostaglandin E2 Receptor 4 (EP4) Agonists for the Treatment of Gastrointestinal and Pulmonary Diseases
0 cites
US12441777utility2025
GLP-1 Receptor Antagonists
0 cites
US12415795utility2025
4-(3-cyanophenyl)-6-pyridinylpyrimidine Mglu5 Modulators
0 cites
US12344621utility2025
CGRP Antagonist Compounds
0 cites
US12331029utility2025
Orexin 1 Receptor Antagonists
0 cites
US12291512utility2025
Oxime Compounds as Agonists of the Muscarinic M 1 And/or M 4 Receptor
0 cites
US12240825utility2025
Oxexin 1 Receptor Antagonists
0 cites
US12234227utility2025
Pyrazole Derivatives as H4 Antagonist Compounds
0 cites
US12227521utility2025
CGRP Antagonist Compounds
0 cites
US12215099utility2025
Quinolinone and Benzoxazine Derivatives as Muscarinic M 1 And/or M 4 Receptor Agonists
0 cites
US12202843utility2025
Muscarinic Receptor Agonists
0 cites
US12178813utility2024
CGRP Receptor Antagonists
0 cites
US12054472utility2024
1,2,4-triazine-4-amine Derivatives
0 cites